Search research articles
Contact Us
Filters
Showing results (111-120 of 126) with videos related to
Page
of 13
Sort By:
The Canadian Journal of Cardiology
|
February 25, 2014
Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT)
Stephen B Wilton, Derek V Exner, Jeffrey S Healey, et al.
JACC. Clinical Electrophysiology
|
May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial
Kathryn Coyle, Doug Coyle, Isabelle Nault, et al.
Circulation
|
October 22, 2019
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial
Jason G Andrade, Jean Champagne, Marc Dubuc, et al.
Circulation. Heart Failure
|
October 18, 2017
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials
Michael E Nassif, Yuanyuan Tang, John G Cleland, et al.
Circulation
|
February 24, 2017
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])
Ratika Parkash, George A Wells, John L Sapp, et al.
Circulation. Heart Failure
|
August 17, 2012
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)
Jeff S Healey, Stefan H Hohnloser, Derek V Exner, et al.
Circulation
|
March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
Ratika Parkash, George A Wells, Jean Rouleau, et al.
The New England Journal of Medicine
|
June 23, 2006
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation
Michael H Gollob, Douglas L Jones, Andrew D Krahn, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 25, 2014
Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy
Vidal Essebag, Jacqueline Joza, David H Birnie, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial
Pablo B Nery, George A Wells, Anthony S L Tang, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 126) with videos related to
Sort By:
Page
of 13
The Canadian Journal of Cardiology
|
February 25, 2014
Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT)
Stephen B Wilton, Derek V Exner, Jeffrey S Healey, et al.
JACC. Clinical Electrophysiology
|
May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial
Kathryn Coyle, Doug Coyle, Isabelle Nault, et al.
Circulation
|
October 22, 2019
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial
Jason G Andrade, Jean Champagne, Marc Dubuc, et al.
Circulation. Heart Failure
|
October 18, 2017
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials
Michael E Nassif, Yuanyuan Tang, John G Cleland, et al.
Circulation
|
February 24, 2017
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])
Ratika Parkash, George A Wells, John L Sapp, et al.
Circulation. Heart Failure
|
August 17, 2012
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT)
Jeff S Healey, Stefan H Hohnloser, Derek V Exner, et al.
Circulation
|
March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
Ratika Parkash, George A Wells, Jean Rouleau, et al.
The New England Journal of Medicine
|
June 23, 2006
Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation
Michael H Gollob, Douglas L Jones, Andrew D Krahn, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 25, 2014
Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy
Vidal Essebag, Jacqueline Joza, David H Birnie, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial
Pablo B Nery, George A Wells, Anthony S L Tang, et al.
Page
of 13